ZEMURON Side Effects

6885220-9 | Erythema, Infusion Site Erythema
on Jul 29, 2010 Female patient from UNITED STATES , 46 years of age, weighting 200.0 lb, was diagnosed with endotracheal intubation, paralysis (What is paralysis?) and was treated with Zemuron (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, infusion site erythema. Zemuron dosage: . During the same period patient was treated with DEMEROL (View Demerol Review and Demerol Label ), VERSED (View Versed Review and Versed Label ).

6734503-1 | Bronchospasm, Hypotension, Rash
Patient was taking Zemuron (View Usage). Patient had the following side effects: bronchospasm, hypotension, rash (What is rash?) on Sep 11, 2009 from UNITED STATES Additional patient health information: Male patient , 66 years of age, was diagnosed with induction of anaesthesia and. Zemuron dosage: 50 Mg; ;inbo. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

6734465-7 | Bronchospasm, Hypotension, Rash
Adverse event was reported on Sep 11, 2009 by a Male patient taking Zemuron (View Usage) (Dosage: 100 Mg;once;iv) was diagnosed with neuromuscular blockade and. Location: UNITED STATES , 63 years of age, After Zemuron was administered, patient had the following side effects: bronchospasm, hypotension, rash (What is rash?). During the same period patient was treated with MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), SUCCINYLCHOLINE (View Succinylcholine Review and Succinylcholine Label ), ETOMIDATE (View Etomidate Review and Etomidate Label ), ZUMERON (View Zumeron Review and Zumeron Label ). Patient was hospitalized.

6732897-4 | Toxicologic Test Abnormal
on May 11, 2010 Male patient from UNITED STATES , 18 years of age, was treated with Zemuron (View Usage). Patient experienced the following unwanted or unexpected effects: toxicologic test abnormal. Zemuron dosage: .


6443249-9 | Electromechanical Dissociation, Hypotension, Tachycardia
on Nov 06, 2009 Male patient from UNITED STATES , 48 years of age, was treated with Zemuron (View Usage). Patient had the following side effects: electromechanical dissociation, hypotension, tachycardia. Zemuron dosage: ; Once; Iv. During the same period patient was treated with VERSED (View Versed Review and Versed Label ), MORPHINE (View Morphine Review and Morphine Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), PROPOFOL (View Propofol Review and Propofol Label ), SUCCINYLCHOLINE (View Succinylcholine Review and Succinylcholine Label ). Patient was hospitalized.

6356240-8 | Airway Complication Of Anaesthesia, Procedural Hypotension, Rash
Patient was taking Zemuron (View Usage). After Zemuron was administered, patient had the following side effects: airway complication of anaesthesia, procedural hypotension, rash (What is rash?) on Sep 14, 2009 from UNITED STATES Additional patient health information: Male patient , 63 years of age, weighting 240.0 lb, was diagnosed with neuromuscular blockade and. Zemuron dosage: 100 Mg Once Iv Bolus.

6355982-8 | Electromechanical Dissociation, Hypotension
Adverse event was reported on Sep 14, 2009 by a Male patient taking Zemuron (View Usage) (Dosage: Bolus Dose) was diagnosed with endotracheal intubation, neuromuscular blockade and. Location: UNITED STATES , 48 years of age, weighting 219.0 lb, Patient experienced the following unwanted or unexpected effects: electromechanical dissociation, hypotension.

6182164-5 | Bronchospasm, Hypoxia, Wheezing
on May 05, 2009 Female patient from UNITED STATES , weighting 269.0 lb, was treated with Zemuron (View Usage). Patient had the following side effects: bronchospasm, hypoxia, wheezing. Zemuron dosage: 50 Mg Once Iv Bolus Once. Patient was hospitalized.

6172565-3 | Anaphylactic Reaction, Gastric Disorder, Ileus, Intestinal Ischaemia, No Therapeutic Response
on Apr 16, 2009 Male patient from UNITED STATES , 49 years of age, weighting 259.9 lb, was treated with Zemuron (View Usage). After Zemuron was administered, patient had the following side effects: anaphylactic reaction, gastric disorder, ileus, intestinal ischaemia, no therapeutic response. Zemuron dosage: 3 Ml Intravenous (nos). During the same period patient was treated with LIDOCAINE (View Lidocaine Review and Lidocaine Label ), PROPOFOL (View Propofol Review and Propofol Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ). Patient was hospitalized.

6081201-6 | Thermal Burn, Victim Of Homicide
Patient was taking Zemuron (View Usage). Patient experienced the following unwanted or unexpected effects: thermal burn, victim of homicide on Feb 06, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 229.9 lb, . Zemuron dosage: Not Known As It Was Not Used For A Surgical Procedure.

6067348-9 | Respiratory Rate Increased
Adverse event was reported on Feb 04, 2009 by a Female patient taking Zemuron (View Usage) (Dosage: 60mg Iv Bolus 30mg 20minutes Later Iv Bolus) was diagnosed with repetitive strain injury and. Location: UNITED STATES , 16 years of age, weighting 116.0 lb, Patient had the following side effects: respiratory rate increased.

5956783-2 | Neuromuscular Block Prolonged
on Jan 11, 2008 Female patient from UNITED STATES , 20 years of age, was diagnosed with endotracheal intubation and was treated with Zemuron (View Usage). After Zemuron was administered, patient had the following side effects: neuromuscular block prolonged. Zemuron dosage: Df Intravenous (nos), 20-30 Mg. During the same period patient was treated with SUCCINYLOCHOLINE (Df Intravenous (nos)) (View Succinylocholine Review and Succinylocholine Label ), NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ), ROBINUL (View Robinul Review and Robinul Label ).

5921364-3 | Psychotic Behaviour
on Oct 02, 2008 Female patient from BELGIUM , 24 years of age, was diagnosed with neuromuscular blockade reversal and was treated with Zemuron (View Usage). Patient experienced the following unwanted or unexpected effects: psychotic behaviour. Zemuron dosage: 249 Mg Once/125 Mg Once, Intravenous Bolus. During the same period patient was treated with ROCURONIUM BROMIDE (3.7 Mg Once/7.5 Mg Once, Intravenous Bolus) (View Rocuronium Bromide Review and Rocuronium Bromide Label ), REMIFENTANIL (View Remifentanil Review and Remifentanil Label ), PROPOFOL (View Propofol Review and Propofol Label ).

5765108-7 | Anaphylactic Shock, Blood Pressure Decreased, Bronchospasm, Collapse Of Lung
Patient was taking Zemuron (View Usage). Patient had the following side effects: anaphylactic shock, blood pressure decreased, bronchospasm, collapse of lung on May 29, 2008 from UNITED STATES Additional patient health information: Male patient , 56 years of age, was diagnosed with endotracheal intubation, surgery (What is surgery?) and. Zemuron dosage: Intravenous (nos), Dose: Between 40 And 50 Cc. During the same period patient was treated with GELFOAM (View Gelfoam Review and Gelfoam Label ). Patient was hospitalized.

5760321-7 | Dyspnoea
Adverse event was reported on May 20, 2008 by a Female patient taking Zemuron (View Usage) (Dosage: Df) . Location: UNITED STATES , 80 years of age, After Zemuron was administered, patient had the following side effects: dyspnoea. Patient was hospitalized.

5695708-4 | Anaphylactic Reaction, Atrial Fibrillation, Cardio-respiratory Arrest, Hypotension, Ventricular Fibrillation
on Mar 27, 2008 Female patient from UNITED STATES , 41 years of age, was treated with Zemuron (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, atrial fibrillation (What is atrial fibrillation?), cardio-respiratory arrest, hypotension, ventricular fibrillation. Zemuron dosage: Df. Patient was hospitalized.

5663743-8 | Apnoea, Atrial Fibrillation, Cerebrovascular Spasm, Computerised Tomogram Abnormal, Csf Test Abnormal, Infarction, Loss Of Consciousness, Renal Failure
on Feb 27, 2008 Male patient from UNITED STATES , 61 years of age, weighting 220.5 lb, was diagnosed with induction of anaesthesia and was treated with Zemuron (View Usage). Patient had the following side effects: apnoea, atrial fibrillation (What is atrial fibrillation?), cerebrovascular spasm, computerised tomogram abnormal, csf test abnormal, infarction, loss of consciousness, renal failure. Zemuron dosage: 10 Mg Once Intravenous (nos). During the same period patient was treated with AMIDATE (20 Mg Once Intravenous (nos)) (View Amidate Review and Amidate Label ), OXYGEN (View Oxygen Review and Oxygen Label ).

5621598-1 | Cardio-respiratory Arrest
Patient was taking Zemuron (View Usage). After Zemuron was administered, patient had the following side effects: cardio-respiratory arrest on Jan 30, 2008 from UNITED STATES Additional patient health information: Male patient , 42 years of age, weighting 210.1 lb, was diagnosed with neuromuscular blockade and. Zemuron dosage: 50 Mg Once Intravenous (nos). Patient was hospitalized.

5614613-2 | Blood Pressure Decreased, Cardio-respiratory Arrest
Adverse event was reported on Jan 23, 2008 by a Male patient taking Zemuron (View Usage) (Dosage: 50 Mg Once Intravenous (nos)) was diagnosed with neuromuscular blockade and. Location: UNITED STATES , 42 years of age, weighting 210.1 lb, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, cardio-respiratory arrest. Patient was hospitalized.

5606587-5 | Cardio-respiratory Arrest, Procedural Complication
on Jan 18, 2008 Male patient from UNITED STATES , 42 years of age, weighting 210.1 lb, was diagnosed with neuromuscular blockade and was treated with Zemuron (View Usage). Patient had the following side effects: cardio-respiratory arrest, procedural complication. Zemuron dosage: 50 Mg Once. Patient was hospitalized.

5373007-8 | Anaphylactic Reaction, Cardiac Arrest, Cardiomyopathy
on Jun 19, 2007 Female patient from UNITED STATES , 41 years of age, weighting 163.1 lb, was treated with Zemuron (View Usage). After Zemuron was administered, patient had the following side effects: anaphylactic reaction, cardiac arrest (What is cardiac arrest?), cardiomyopathy (What is cardiomyopathy?). Zemuron dosage: 30 Mg Once Intravenous (n0s).

5345698-9 | Anaphylactic Shock
Patient was taking Zemuron (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock on Feb 16, 2007 from UNITED STATES Additional patient health information: Female patient , 57 years of age, was diagnosed with surgery (What is surgery?) and. Zemuron dosage: . During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).

5345695-3 | Neuromuscular Block Prolonged
Adverse event was reported on Jan 25, 2007 by a Female patient taking Zemuron (View Usage) (Dosage: 80 Mg Intravenous (nos), Over Three Doses) . Location: UNITED STATES , 81 years of age, Patient had the following side effects: neuromuscular block prolonged.

5345690-4 | Anaphylactic Reaction
on Oct 31, 2006 Male patient from UNITED STATES , 74 years of age, weighting 180.8 lb, was diagnosed with intubation and was treated with Zemuron (View Usage). After Zemuron was administered, patient had the following side effects: anaphylactic reaction. Zemuron dosage: 50 Mg Daily Intravenous (nos). During the same period patient was treated with VERSED (View Versed Review and Versed Label ), PHENTANYL NOS (View Phentanyl Nos Review and Phentanyl Nos Label ).

5345685-0 | Neuromuscular Block Prolonged
on Sep 06, 2006 Female patient from UNITED STATES , 72 years of age, was diagnosed with neuromuscular blockade and was treated with Zemuron (View Usage). Patient experienced the following unwanted or unexpected effects: neuromuscular block prolonged. Zemuron dosage: 50 Mg Once.

5345684-9 | Neuromuscular Block Prolonged
Patient was taking Zemuron (View Usage). Patient had the following side effects: neuromuscular block prolonged on Sep 06, 2006 from UNITED STATES Additional patient health information: Female patient , 61 years of age, was diagnosed with neuromuscular blockade and. Zemuron dosage: 25 Mg Once.

5345681-3 | Neuromuscular Block Prolonged
Adverse event was reported on Sep 06, 2006 by a Female patient taking Zemuron (View Usage) (Dosage: 20 Mg Once) was diagnosed with neuromuscular blockade and. Location: UNITED STATES , 30 years of age, After Zemuron was administered, patient had the following side effects: neuromuscular block prolonged.

5345679-5 | Neuromuscular Block Prolonged
on Sep 06, 2006 Female patient from UNITED STATES , 35 years of age, was diagnosed with neuromuscular blockade and was treated with Zemuron (View Usage). Patient experienced the following unwanted or unexpected effects: neuromuscular block prolonged. Zemuron dosage: . During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ). Patient was hospitalized.

5345677-1 | Anaphylactic Shock
on Apr 25, 2006 Male patient from UNITED STATES , 78 years of age, was diagnosed with neuromuscular blockade and was treated with Zemuron (View Usage). Patient had the following side effects: anaphylactic shock. Zemuron dosage: 50 Mg Once. Patient was hospitalized.

5186267-3 | Hypotonia, Post Procedural Complication
Patient was taking Zemuron (View Usage). After Zemuron was administered, patient had the following side effects: hypotonia, post procedural complication on Nov 28, 2006 from UNITED STATES Additional patient health information: Male patient , 60 years of age, weighting 200.6 lb, was diagnosed with neuromuscular blockade and. Zemuron dosage: 5 Mg Once Intravenous (nos), Induction Dose. During the same period patient was treated with HYPERTENSION MEDICATIOM (View Hypertension Medicatiom Review and Hypertension Medicatiom Label ). Patient was hospitalized.

5131193-9 | Anaesthetic Complication, Anaphylactic Shock
Adverse event was reported on Oct 17, 2006 by a Female patient taking Zemuron (View Usage) (Dosage: ) was diagnosed with anaesthesia, surgery (What is surgery?) and. Location: UNITED STATES , 35 years of age, weighting 165.0 lb, Patient experienced the following unwanted or unexpected effects: anaesthetic complication, anaphylactic shock. Patient was hospitalized.

5130273-1 | Delayed Recovery From Anaesthesia, Procedural Complication
on Oct 18, 2006 Female patient from UNITED STATES , 75 years of age, weighting 249.1 lb, was diagnosed with surgery (What is surgery?) and was treated with Zemuron (View Usage). Patient had the following side effects: delayed recovery from anaesthesia, procedural complication. Zemuron dosage: 50mg, Then 20mgx2 Then 10mg X 1 Once Q30min Iv Bolus. Patient was hospitalized.

5105190-3 | Asthenia, Blood Pressure Increased, Dyspnoea, Electrocardiogram Qt Prolonged, Electrocardiogram St Segment Depression, Heart Rate Increased
on Aug 31, 2006 Female patient from UNITED STATES , 75 years of age, weighting 178.4 lb, was diagnosed with neuromuscular blockade and was treated with Zemuron (View Usage). After Zemuron was administered, patient had the following side effects: asthenia, blood pressure increased, dyspnoea, electrocardiogram qt prolonged, electrocardiogram st segment depression, heart rate increased. Zemuron dosage: 30 Mg Once Intravenus (nos). During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ). Patient was hospitalized.

5090944-2 | Asthenia, Blood Pressure Increased, Depressed Level Of Consciousness, Electrocardiogram Qt Prolonged, Electrocardiogram St Segment Depression, Heart Rate Increased
Patient was taking Zemuron (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood pressure increased, depressed level of consciousness, electrocardiogram qt prolonged, electrocardiogram st segment depression, heart rate increased on Aug 11, 2006 from UNITED STATES Additional patient health information: Female patient , 75 years of age, weighting 178.4 lb, was diagnosed with neuromuscular blockade and. Zemuron dosage: 30 Mg Once Intravenous (nos). During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ).

5088340-7 | Asthenia, Blood Pressure Increased, Dyspnoea, Electrocardiogram Qt Prolonged, Electrocardiogram St Segment Depression, Heart Rate Increased, Muscular Weakness
Adverse event was reported on Aug 11, 2006 by a Female patient taking Zemuron (View Usage) (Dosage: 20 Mg Once Intravenous (nos)) was diagnosed with neuromuscular blockade and. Location: UNITED STATES , 75 years of age, weighting 178.4 lb, Patient had the following side effects: asthenia, blood pressure increased, dyspnoea, electrocardiogram qt prolonged, electrocardiogram st segment depression, heart rate increased, muscular weakness. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ). Patient was hospitalized.

5082588-3 | Neuromuscular Block Prolonged
on Aug 03, 2006 Female patient from UNITED STATES , 75 years of age, weighting 178.4 lb, was diagnosed with neuromuscular blockade and was treated with Zemuron (View Usage). After Zemuron was administered, patient had the following side effects: neuromuscular block prolonged. Zemuron dosage: 20 Mg Once Intravenous (nos). During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ).

5023447-1 | Neuromuscular Block Prolonged
on Feb 16, 2006 Female patient from UNITED STATES , 48 years of age, weighting 142.4 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with Zemuron (View Usage). Patient experienced the following unwanted or unexpected effects: neuromuscular block prolonged. Zemuron dosage: Df Intravenous (nos). During the same period patient was treated with ONDANSETRON HCL (4 Mg Intravenous (nos)) (View Ondansetron Hcl Review and Ondansetron Hcl Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

5023437-9 | Neuromuscular Block Prolonged
Patient was taking Zemuron (View Usage). Patient had the following side effects: neuromuscular block prolonged on Jan 12, 2006 from UNITED STATES Additional patient health information: Female patient , 67 years of age, weighting 190.0 lb, was diagnosed with hypotonia, intubation and. Zemuron dosage: 20 Mg Once Intravenous (nos). During the same period patient was treated with ANECTINE (60 Mg Once Intravenous (nos)) (View Anectine Review and Anectine Label ), PROPOFOL (View Propofol Review and Propofol Label ), DESFLURANE (View Desflurane Review and Desflurane Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), MORPHINE (View Morphine Review and Morphine Label ), DECADRON (View Decadron Review and Decadron Label ), NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ).

5023428-8 | Neuromuscular Block Prolonged
Adverse event was reported on Sep 08, 2005 by a Male patient taking Zemuron (View Usage) (Dosage: 60 Mg Once Intravenous (nos)) was diagnosed with intubation and. Location: UNITED STATES , weighting 176.4 lb, After Zemuron was administered, patient had the following side effects: neuromuscular block prolonged.

4690012-5 | Neuromuscular Block Prolonged
on Dec 23, 2004 Female patient from , 64 years of age, weighting 175.3 lb, was diagnosed with intubation and was treated with Zemuron (View Usage). Patient experienced the following unwanted or unexpected effects: neuromuscular block prolonged. Zemuron dosage: 50 Mg Intravenous (nos). During the same period patient was treated with NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ), ROBINUL (View Robinul Review and Robinul Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), VERSED (View Versed Review and Versed Label ).

4690011-3 | Anaphylactoid Reaction
on Dec 07, 2004 Female patient from , 32 years of age, weighting 230.4 lb, was treated with Zemuron (View Usage). Patient had the following side effects: anaphylactoid reaction. Zemuron dosage: 10 Mg Once Intravenous (nos). During the same period patient was treated with SUCCINYLCHOLINE (View Succinylcholine Review and Succinylcholine Label ), PROPOFOL (View Propofol Review and Propofol Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ).

4678768-9 | Cardiac Arrest, Myocardial Infarction, Procedural Complication
Patient was taking Zemuron (View Usage). After Zemuron was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), myocardial infarction, procedural complication on May 06, 2005 from Additional patient health information: Female patient , 64 years of age, weighting 240.3 lb, was diagnosed with anaesthesia and. Zemuron dosage: Df Intravenous (nos). During the same period patient was treated with DIPRIVAN (Intravenous (nos)) (View Diprivan Review and Diprivan Label ).

4662092-4 | Cardiac Arrest, Myocardial Infarction
Adverse event was reported on May 04, 2005 by a Female patient taking Zemuron (View Usage) (Dosage: Df Intravenous (nos)) was diagnosed with induction of anaesthesia and. Location: , 68 years of age, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), myocardial infarction. During the same period patient was treated with DIPRIVAN (Intravenous (nos)) (View Diprivan Review and Diprivan Label ).

4651634-0 | Neuromuscular Block Prolonged
on Apr 20, 2005 Male patient from , 75 years of age, weighting 308.6 lb, was treated with Zemuron (View Usage). Patient had the following side effects: neuromuscular block prolonged. Zemuron dosage: 50 Mg. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4649986-0 | Cardiac Arrest, Myocardial Infarction
on Apr 22, 2005 Female patient from , 68 years of age, was treated with Zemuron (View Usage). After Zemuron was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), myocardial infarction. Zemuron dosage: Df Intravenous (nos). During the same period patient was treated with DIPRIVAN (Intravenous (nos)) (View Diprivan Review and Diprivan Label ).

4647781-X | Neuromuscular Block Prolonged
Patient was taking Zemuron (View Usage). Patient experienced the following unwanted or unexpected effects: neuromuscular block prolonged on Apr 27, 2005 from Additional patient health information: Male patient , weighting 140.0 lb, was diagnosed with neuromuscular blockade and. Zemuron dosage: 50mg One Time Intravenous. Patient was hospitalized.

4618587-2 | Coma, Hypokinesia, Somnolence
Adverse event was reported on Dec 02, 2004 by a Male patient taking Zemuron (View Usage) (Dosage: 2 Mg Once) was diagnosed with intubation and. Location: , weighting 5.51 lb, Patient had the following side effects: coma, hypokinesia, somnolence. During the same period patient was treated with ATIVAN (View Ativan Review and Ativan Label ).

4615148-6 | Anaesthetic Complication Neurological, Paralysis
on Feb 24, 2005 Female patient from , 64 years of age, weighting 141.1 lb, was diagnosed with intubation and was treated with Zemuron (View Usage). After Zemuron was administered, patient had the following side effects: anaesthetic complication neurological, paralysis (What is paralysis?). Zemuron dosage: 100 Mg Once Intravenous (nos). During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), OXYGEN (View Oxygen Review and Oxygen Label ), DESFLURANE (View Desflurane Review and Desflurane Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), DEMEROL (View Demerol Review and Demerol Label ), VERSED (View Versed Review and Versed Label ), ANCEF (View Ancef Review and Ancef Label ).

4591957-7 | Anaesthetic Complication Neurological, Paralysis
on Feb 09, 2005 Female patient from , 64 years of age, weighting 141.1 lb, was diagnosed with intubation and was treated with Zemuron (View Usage). Patient experienced the following unwanted or unexpected effects: anaesthetic complication neurological, paralysis (What is paralysis?). Zemuron dosage: 100 Mg Once Intravenous( Nos). During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).